Overall, 54% stated that such trials are “strongly needed,” with an additional 39% answering that they are “sometimes needed,” and only 7% indicating that they are "rarely needed." A stratified analysis based on the proportion of patients who declined trial participation owing to travel distance revealed a clear trend: institutions with higher abandonment rates reported a stronger need for online-enabled trials.
← all excerpts
Bridging the distance in precision oncology: a nationwide survey on institutional perspectives toward telemedicine and decentralized trials in Japan.
1
—
—